In another study, Redd et al [58] examined peripheral blood mononuclear cell samples from PCR-confirmed, recovered/convalescent COVID-19 cases (N=30) for their anti-SARS-CoV-2 CD8+ T-cell responses with Omicron. The gene discussed is CD8A; the disease is COVID-19.